RN0361, an siRNA Directed Against ApoC3 Demonstrates Potent and Durable Reduction of ApoC3 and Triglyceride Over 6 Months in the Clinic
1. 系统已在2026-07-21 17:35:08对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
A DePaoli, A Zhu, D Xiang, Y Shi
Circulation, 2025
ovid.com
4361462: RN0361, an siRNA Directed... : Circulation Ovid Logo Search Ovid Browse Login
Circulation Navbar Menu Issues About Journal For Authors More menu items Search Journal
Button group. Outline Permissions Share Cite Favorite Clinical Trials, Quality and Outcomes
Research: Session Title: From Molecules to Models: Redefining Cardiovascular Care Across
Systems and Syndromes Crossmark: Check for updates Abstract 4361462: RN0361, an
siRNA Directed Against ApoC3 Demonstrates Potent and Durable Reduction of ApoC3 and …
